Cargando…

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial

INTRODUCTION: Research in recent years has shown the potential benefits of fecal microbiota transplantation (FMT) for irritable bowel syndrome (IBS). Acute infectious gastroenteritis is a well-established risk factor for developing such forms of IBS as post-infectious IBS (PI-IBS). However, the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tkach, Sergii, Dorofeyev, Andrii, Kuzenko, Iurii, Sulaieva, Oksana, Falalyeyeva, Tetyana, Kobyliak, Nazarii
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631772/ https://www.ncbi.nlm.nih.gov/pubmed/36341232 http://dx.doi.org/10.3389/fmed.2022.994911

Ejemplares similares

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
por: Tkach, Sergii, et al.
Publicado: (2022)

Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial
por: Tkach, Sergii, et al.
Publicado: (2023)

Resveratrol Effects on the Reproductive System in Ovariectomized Rats: Deciphering Possible Mechanisms
por: Zaychenko, Ganna, et al.
Publicado: (2022)

Pathophysiological role of host microbiota in the development of obesity
por: Kobyliak, Nazarii, et al.
Publicado: (2016)

Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
por: Mashukov, Artem, et al.
Publicado: (2021)

Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019)

Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment
por: Sulaieva, Oksana, et al.
Publicado: (2020)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
por: Savcheniuk, Oleksandr, et al.
Publicado: (2014)

Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment
por: Manzhalii, Elina, et al.
Publicado: (2022)

Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
por: Savytska, Maryana, et al.
Publicado: (2023)

Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?
por: Ryspayeva, Dinara, et al.
Publicado: (2022)

Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis
por: Stakhovskyi, Oleksandr, et al.
Publicado: (2022)

Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles
por: KOBYLIAK, NAZARII, et al.
Publicado: (2016)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention
por: Kobyliak, Nazarii, et al.
Publicado: (2016)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Antimicrobial activity of dietary supplements based on bacterial lysate of Lactobacillus rhamnosus DV
por: Penchuk, Yurii, et al.
Publicado: (2023)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome
por: Goll, Rasmus, et al.
Publicado: (2020)

Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
por: Rodrigues, Tânia, et al.
Publicado: (2023)

Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
por: Samuthpongtorn, Chatpol, et al.
Publicado: (2022)

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2023)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
por: Petakh, Pavlo, et al.
Publicado: (2023)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022)

Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Hui-jun, et al.
Publicado: (2022)

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan
por: Hamazaki, Motonobu, et al.
Publicado: (2022)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility
por: Kobyliak, Nazarii M., et al.
Publicado: (2015)

Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea
por: Huang, Hong-Li, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jamshidi, Parnian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a08e69fmrn23soif95rvbkdpcv